PMDA — authorised 3 July 2017
- Marketing authorisation holder: Celgene KK
- Status: approved
🇯🇵 Istodax in Japan
PMDA authorised Istodax on 3 July 2017
Marketing authorisation
Istodax in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Istodax approved in Japan?
Yes. PMDA authorised it on 3 July 2017.
Who is the marketing authorisation holder for Istodax in Japan?
Celgene KK holds the Japanese marketing authorisation.